googlemarker

DR. REDDYS LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01023Industry : Pharmaceuticals & Drugs MCap (Rs. in Mn) : 384294.44 Face Value (Rs.) : 5 House : Dr. Reddy's
BSE2314.55-46.8 (-1.98 %)
PREV CLOSE (Rs.) 2361.35
OPEN PRICE (Rs.) 2340.00
BID PRICE (QTY) 2314.50 (2)
OFFER PRICE (QTY) 2316.45 (38)
VOLUME 235808
TODAY'S LOW / HIGH (Rs.)2304.30 2350.30
52 WK LOW / HIGH (Rs.)1901.65 3247
NSE2312.30-48.35 (-2.05 %)
PREV CLOSE( Rs. ) 2360.65
OPEN PRICE (Rs.) 2361.05
BID PRICE (QTY) 2312.05 (4)
OFFER PRICE (QTY) 2312.30 (5)
VOLUME 563801
TODAY'S LOW / HIGH(Rs.) 2300.10 2367.00
52 WK LOW / HIGH (Rs.)1901.15 3247.25
1D 1M 3M 1Y 3Y 5Y
Trade Value (Rs. in Lacs)
5457.89
Dividend Yield(%)
0.86
TTM EPS (Rs.)
45.52
P/E Ratio
50.89
Book Value (Rs.)
682.01
Face Value (Rs.)
5
MCap (Rs. in Mn)
384294.44
Price/Earning (TTM)
25.38
Price/Sales (TTM)
4.20
Price/Book (MRQ)
3.40
PAT Margin (%)
14.24
ROCE (%)
11.00
Incorporation Year : 24-02 1984

Management Info :

K Satish Reddy - Chairman GV Prasad - Managing Director

Registered Office :

Address : 8-2-337, Road No. 3,Banjara Hills,,
Hyderabad,
Telangana-500034

Phone : 040 - 4900 2900

Website : www.drreddys.com

Registrars Details :

Bigshare Services Pvt Ltd
306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad
Listing : BSE, NSE, MCX, New York
21Nov Dr. Reddy’s receives EIR from USFDA fo
Dr. Reddy’s Laboratories has received the Establishment Inspection Repor..
21Nov Dr. Reddys Laboratories informs about
Dr. Reddys Laboratories has informed about receipt of EIR.The above info..
14Nov Dr. Reddy’s launches Clofarabine Injec
Dr. Reddy’s Laboratories has launched Clofarabine Injection, a therapeut..
QTR Sep 17 ANNUAL 17
Net Profit100713841
Gross Profit 1402 15445
Operating Profit 3540 23368
Net Sales 22543 97198
Rs. in Millions
Zandu Realty (BSE)
img  2014.40 (3.00%)
M.Cap (Rs. in Cr)162.09
Shilpa Medicare (BSE)
img  663.85 (4.30%)
M.Cap (Rs. in Cr)5313.22
Panacea Biotec (BSE)
img  283.60 (7.73%)
M.Cap (Rs. in Cr)1740.75
Glaxosmithkline Phar (BSE)
img  2515.00 (0.78%)
M.Cap (Rs. in Cr)21260.46
PROMOTERS
26.77%
NON-INSTITUTION
15.25%
MUTUAL FUNDS/UTI
7.51%
FI/BANKS/INSURANCE
5.92%
GOVERNMENT
0%
FII
0%
Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.....Issued in the interest of investors.  |  No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. |  KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Dear Client, Pursuant to SEBI regulation, update your KYC details through KRA form with supporting documents at earliest to complete KYC-KRA requirement. If already submitted, kindly ignore. For any information, in this regard, please contact to our KYC Department on 022-66556772/73/74 or email at kyc@satco.co.in.
  • NSE - INZ 230012635 | 
  • BSE - INZ 010012839 | 
  • MCX - IN2000026431 / FMC : MCX/TCM/CORP/0598  | 
  • NCDEX - IN2000026431 / FMC : NCDEX/TM/CORP/1138 | 
  • CDSL – IN-DP-CDSL-727-2014  | 
  • PMS - INP000003492  | 
  • RESEARCH – INH000002343
  • SATCO CAPITAL MARKETS LTD. All rights reserved. || Designed Developed & Content Powered By Accord Fintech Pvt.Ltd.
VISIT COUNT     388171